279 related articles for article (PubMed ID: 29209123)
21. Identification of prognostic biomarkers of hepatocellular carcinoma via long noncoding RNA expression and copy number alterations.
Du W; Chen W; Shu Z; Xiang D; Bi K; Lu Y; Zhang X; Li L; Diao H
Epigenomics; 2020 Aug; 12(15):1303-1315. PubMed ID: 32772564
[No Abstract] [Full Text] [Related]
22. Sex-related differences in DNA copy number alterations in hepatitis B virus-associated hepatocellular carcinoma.
Zhu ZZ; Wang D; Cong WM; Jiang H; Yu Y; Wen BJ; Dong H; Zhang X; Liu SF; Wang AZ; Zhu G; Hou L
Asian Pac J Cancer Prev; 2012; 13(1):225-9. PubMed ID: 22502674
[TBL] [Abstract][Full Text] [Related]
23. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
24. Multiple-level copy number variations in cell-free DNA for prognostic prediction of HCC with radical treatments.
Wang Y; Zhou K; Wang X; Liu Y; Guo D; Bian Z; Su L; Liu K; Gu X; Guo X; Wang L; Zhang H; Tao K; Xing J
Cancer Sci; 2021 Nov; 112(11):4772-4784. PubMed ID: 34490703
[TBL] [Abstract][Full Text] [Related]
25. Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma.
Lu T; Hano H; Meng C; Nagatsuma K; Chiba S; Ikegami M
World J Gastroenterol; 2007 Feb; 13(7):1090-7. PubMed ID: 17373745
[TBL] [Abstract][Full Text] [Related]
26. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
28. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
29. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
Li S; Wang H; Zhang C
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):577-81. PubMed ID: 11798820
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Screening of Gene Copy Number Aberrations in Formalin-Fixed, Paraffin-Embedded Solid Tumors Using Molecular Inversion Probe-Based Single-Nucleotide Polymorphism Array.
Singh RR; Mehrotra M; Chen H; Almohammedsalim AA; Sahin A; Bosamra A; Patel KP; Routbort MJ; Lu X; Ronald A; Mishra BM; Virani S; Medeiros LJ; Luthra R
J Mol Diagn; 2016 Sep; 18(5):676-687. PubMed ID: 27392636
[TBL] [Abstract][Full Text] [Related]
31. Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma.
Kim H; Lee MJ; Kim MR; Chung IP; Kim YM; Lee JY; Jang JJ
Liver; 2000 Apr; 20(2):173-8. PubMed ID: 10847487
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China.
Li SP; Wang HY; Li JQ; Zhang CQ; Feng QS; Huang P; Yu XJ; Huang LX; Liang QW; Zeng YX
J Hepatol; 2001 Jun; 34(6):840-9. PubMed ID: 11451167
[TBL] [Abstract][Full Text] [Related]
33. Low-level expression of microRNA-375 predicts poor prognosis in hepatocellular carcinoma.
Zhou N; Wu J; Wang X; Sun Z; Han Q; Zhao L
Tumour Biol; 2016 Feb; 37(2):2145-52. PubMed ID: 26349912
[TBL] [Abstract][Full Text] [Related]
34. Allele loss and down-regulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma.
Huang GL; Li BK; Zhang MY; Wei RR; Yuan YF; Shi M; Chen XQ; Huang L; Zhang HZ; Liu W; Huang BJ; Li H; Zheng XF; Luo XR; Wang HY
PLoS One; 2012; 7(8):e44061. PubMed ID: 22952874
[TBL] [Abstract][Full Text] [Related]
35. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
Dalmasso C; Carpentier W; Guettier C; Camilleri-Broët S; Borelli WV; Campos Dos Santos CR; Castaing D; Duclos-Vallée JC; Broët P
BMC Cancer; 2015 Mar; 15():126. PubMed ID: 25879652
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma.
Ren N; Qin LX; Tu H; Liu YK; Zhang BH; Tang ZY
J Cancer Res Clin Oncol; 2006 Jun; 132(6):399-407. PubMed ID: 16502316
[TBL] [Abstract][Full Text] [Related]
37. Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma.
Tanaka Y; Kanai F; Tada M; Tateishi R; Sanada M; Nannya Y; Ohta M; Asaoka Y; Seto M; Shiina S; Yoshida H; Kawabe T; Yokosuka O; Ogawa S; Omata M
J Hepatol; 2008 Nov; 49(5):746-57. PubMed ID: 18752864
[TBL] [Abstract][Full Text] [Related]
38. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
39. Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma.
Chen CF; Hsu EC; Lin KT; Tu PH; Chang HW; Lin CH; Chen YJ; Gu DL; Lin CH; Wu JY; Chen YT; Hsu MT; Jou YS
Hepatology; 2010 Nov; 52(5):1690-701. PubMed ID: 20799341
[TBL] [Abstract][Full Text] [Related]
40. A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study.
Chochi Y; Kawauchi S; Nakao M; Furuya T; Hashimoto K; Oga A; Oka M; Sasaki K
J Pathol; 2009 Apr; 217(5):677-84. PubMed ID: 19097070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]